Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: Therapeutic implications

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 6, 2006, Pages 577-588

  Michiels, Jan J ^a,d,e   Berneman, Zwi ^a   Gadisseur, Alain ^a   Van Der Planken, Marc ^a   Schroyens, Wilfried ^a   Budde, Ulrich ^b   Van Vliet, Huub H D M ^c  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Coagulation Laboratory   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Goodheart Institute   (Netherlands)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Acquired von Willebrand syndrome (AvWS); Diaqnosis; Hypothyroidism; Monoclonal gammopathy; Systemic lupus erythematosus; Thrombocythemia; Treatment; Wilms' tumor

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CONCENTRATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISONE; RISTOCETIN; THYROXINE; VON WILLEBRAND FACTOR;

AORTA STENOSIS; BLEEDING TENDENCY; BLOOD CLOTTING FACTOR DEFICIENCY; DISEASE ASSOCIATION; HUMAN; HYPOTHYROIDISM; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; MYELOPROLIFERATIVE DISORDER; NEPHROBLASTOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SHEAR STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTHEMIA; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BLOOD PLATELETS; CHEMISTRY, CLINICAL; FACTOR VIII; HUMANS; IMMUNE SYSTEM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MONOCLONAL GAMMOPATHIES, BENIGN; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASES; WILMS TUMOR;

EID: 33748992012     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-949663     Document Type: Review

References (45)

1. Federici AB, Rand JH, Bucciarelli P, et al. Acquired von Willebrand syndrome. Data from an international registry. Thromb Haemost 2000;84:345-349
2. Michiels JJ, Budde U, Van Der Planken M, Van Vliet HHDM, Schroyens W, Berneman Z. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Baillieres Best Pract Res Clin Haematol 2001;14:401-436
3. Budde U, Bergmann F, Michiels JJ. Acquired von Willebrand syndrome. Experience from 2 years in a single laboratory compared with data from the literature and an international registry. Semin Thromb Hemost 2002;28:227-237
4. Mohri H. Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management. J Thromb Thrombolysis 2003;15:141-149
5. Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001;7:113-115
6. Michiels J, Schroyens W, Berneman Z, van der Planken M. Atypical variant of acquired von Willebrand syndrome in Wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause? Clin Appl Thromb Hemost 2001;7:102-107
7. Michiels JJ. Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia. Clin Appl Thromb Hemost 1999;5:147-151
8. Michiels JJ, Berneman Z, Schroyen W, van Vliet HHDM. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding in essential thrombocythemia and polycythemia vera. Platelets 2004;15:67-84
9. Vincelli A, Susen S, Le Tourneau Th, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349
10. Warkentin THE, Moore JC, Anand SS, Lonn EM, Morgan DG. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome. Trans Med Rev 2003;17:272-286
11. Gill JC, Wilson AD, Ebdres-Brooks A, et al. Loss of largest von Willebrand multimers from plasma of patients with congenital cardiac defects. Blood 1986;67:758-761
12. Rauch R, Budde U, Koch A, Hofbek M. Acquired von Willebrand syndrome in children with patent ductus arteriosus. Heart 2002;88:87-88
13. Simone JV, Cornet JA, Abildgard CF. Acquired von Willebrand's syndrome in systemic lupus erythematodes. Blood 1968;31:806-811
14. Ingram GIC, Kigston PJ, Leslie J, Bowie EJW. Four cases of acquired von Willebrand syndrome. Br J Haematol 1971;21:189-199
15. Poole-Wilson PA. Acqired von Willebrand's syndrome and systemic lupus erythematodes. Proc R Soc Med 1972;65:561-562
16. Gazengel G, Prieur AM, Buriot D, Nedellec J, Josso F. Antibody-induced von Willebrand syndrome. Am J Hematol 1978;5:355-363
17. Pizzuto J, Ambriz R, De La Paz Reyna M, et al. Acquired von Willebrand's syndrome during autoimmune disorder. Thromb Haemost 1979;42:1523-1528
18. Hoshida H, Aria K, Wakashin M. Development of Acquired von Willebrand's disease after mixed connective tissue disease. Am J Med 1988;85:445-446
19. Igarashi N, Miura M, Kato E, et al. Acquired von Willebrand's syndrome with lupus-like serology. Am J Pediatr Hematol Oncol 1989;11:32-35
20. Soff GA, Green D. Autoantibody to von Willebrand factor in systemic lupus erythematodes. J Lab Clin Med 1993;121:424-430
21. Hanley D, Arkel YS, Lynch J, Kamiyama M. Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 1994;46:141-146
22. Viallard J-F, Pellegrin JL, Vergnes C, et al. Three cases of acquired von Willebrand disease associated with systemic lupus erythematodes. Br J Haematol 1999;105:532-537
23. Niiya M, Niiya K, Takazawa Y, et al. Acquired type 3-like von Willebrand syndrome preceded by full-blown systemic lupus erythematodes. Blood Coagul Fibrinolysis 2002;13:361-363
24. Casonato A, Pontara E, Doria A, et al. Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome. Br J Haematol 2002;116:899-904
25. Inbal A, Bank I, Zivelin A, et al. Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor. Br J Haematol 1997;96:179-182
26. Fricke W, Brinkhous KM, Garris JB, Roberts HR. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand binding by antibody. Blood 1985;66:562-569
27. Macik BG, Gabriel DA, White GC, High K, Roberts H. The use of high-dose intravenous gammaglobulin in acquired von Willebrand's syndrome. Arch Pathol Lab Med 1988;112:143-146
28. Delannoy A, Saillez AC. High-dose intravenous gammaglobulin for acquired von Willebrand's disease. Br J Haematol 1988;70:387-389
29. Gross S, Traulle C, Capiod JC, et al. Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery. Br J Haematol 1992;82:170-171
30. Castaman G, Tosseto A, Rodeghiero F. Effectiveness of high dose intravenous immunoglobulin in a case of acquired von Willebrand's syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate. Am J Hematol 1992;41:132-136
31. Delmer A, Horellou MH, Brechot JM, et al. Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulin. Am J Hematol 1992;40:151-152
32. White LA, Chisholm M. Gastro-intestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immunoglobulin where substitution treatments failed. Br J Haematol 1993;84:332-334
33. Van Genderen PJJ, Michiels JJ, Bakker JJ, Van't Veer MB. Effectiveness of high-dose intravenous gammaglobulin therapy in acquired von Willebrand's disease. Vox Sang 1994;67:14-17
34. Arkel YS, Lynch J, Kamiyama M. Treatment of acquired von Willebrand syndrome with intravenous immunoglobulin. Thromb Haemost 1994;72:643-644
35. Saillier L, Ecoifier M, Cadroy Y, et al. Association maladie de Willebrand acquise, gammopathie monoclonale, angiopdysplasie du grele: une indication rare des immunoglobulines intraveneuses a forte dose. Rev Med Interne 1996;17:929-932
36. Michiels JJ, Van Vliet HHDM. Acquired von Willebrand disease in monoclonal gammopathies: effectiveness of high-dose intravenous gammoglobulin. Clin Appl Thromb Hemost 1999;5:152-157
37. Frank RD, Kunz D, Wirtz DC. Acquired von Willebrand disease - Hemostatic management of major orthopedic surgery with high dose immunoglobulin, desmopressin, and continuous factor concentrate infusion. Am J Hematol 2002;70:64-71
38. Hayashi T, Yagi H, Susuki H, et al. Low-dosage intravenous immunoglobulin in the management of a patient with acquired von Willebrand syndrome with monoclonal gammopathy of undetermined significance. Pathophysiol Haemost Thromb 2002;32:33-39
39. Van Genderen PJJ, Terpstra W, Michiels JJ, Kapteijn L, Van Vliet HHDM. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease. Thromb Haemost 1995;73:891-892
40. Siaka C, Ruggeri L, Caron C, Goudemand J. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia 2003;9:303-308
41. Federici AB, Stabile F, Castaman G, et al. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches. Blood 1998;92:2707-2711
42. Federici AB. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol 2005;66:422-430
43. Eikenboom JCJ, van der Meer FJM, Briët E. Acquired von Willebrand's syndrome in the course of excessive fibrinolysis. Br J Haematol 1992;67:639-620
44. Scobohaci MJ, Daniel NT, Levy Y, Marolleau JP. Expression of GP Ib on plasma cells in a patient with monoclonal IgG and acquired von Willebrand's disease. Br J Haematol 1993;84:471-475
45. Tefferi A, Hanon CA, Curtin PJ, et al. Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal lymphoma cells. Br J Haematol 1997;96:850-853